CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M ALBUMIN KIT
✉ Email this page to a colleague
All Clinical Trials for Technetium Tc-99m Albumin Kit
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00005821 ↗ | Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer | Unknown status | Royal Marsden NHS Foundation Trust | Phase 2 | 1998-12-01 | RATIONALE: Diagnostic procedures such as sentinel lymph node biopsy may improve the ability to detect breast cancer and determine the extent of disease. PURPOSE: Phase II trial to study the effectiveness of sentinel lymph node biopsy to assess axillary lymph nodes in women who have stage I or stage II breast cancer. |
| NCT00847522 ↗ | Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | Completed | University of Utah | Phase 1/Phase 2 | 2009-02-01 | The purpose of this research study is to use two different drugs to find where melanoma might spread and to remove these tissues. We believe that tumor cells from the melanoma first move through the lymphatic system (a system of clear fluid that moves around the body and carries white blood cells, much like the blood system) to a lymph node in an orderly way. If we can identify the first lymph nodes to receive a tumor cell, this can be removed and examined. We currently use one drug, called "technetium-99m sulfur colloid" which can detect about 90% of the first lymph nodes that the tumor cells would move to. Technetium-99m is a radioactive compound and can be detected through the skin by a special instrument that reads radioactivity. As part of this research, we would like to use a second drug called "fluorescein" (Fluorescite®) to see if it will identify the same lymph nodes or additional ones and examine these. This drug is fluorescent and can be detected even through the skin using a blue light. This drug is approved by the Federal Drug Administration (FDA) to for injection in the vein as a diagnostic aid and has been safely used in people for many years. In this study, we will be injecting it under the skin, which is a different use from how it is currently approved by the FDA. In the past another drug has been used, called "isosulfan blue" (Lymphazurin®), but availability of this drug is currently limited, and it has higher risks associated with it. This study is being conducted by Dr. Robert Andtbacka, Dr. Dirk Noyes, Dr. James McGreevy and at University of Utah. This study is a Phase I/II and is done to find out if the drug can be used safely when given under the skin and if it will work for this purpose. |
| NCT01982123 ↗ | SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy | Completed | National Cancer Institute (NCI) | N/A | 2014-01-17 | This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment. |
| NCT01982123 ↗ | SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy | Completed | University of Washington | N/A | 2014-01-17 | This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Technetium Tc-99m Albumin Kit
Condition Name
Clinical Trial Locations for Technetium Tc-99m Albumin Kit
Trials by Country
Clinical Trial Progress for Technetium Tc-99m Albumin Kit
Clinical Trial Phase
Clinical Trial Sponsors for Technetium Tc-99m Albumin Kit
Sponsor Name
